Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer

M. Beránek, I. Sirák, M. Vošmik, J. Petera, M. Drastíková, V. Palička

. 2016 ; 59 (2) : 54-58.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17010615

The aims of the study were: i) to compare circulating tumor DNA (ctDNA) yields obtained by different manual extraction procedures, ii) to evaluate the addition of various carrier molecules into the plasma to improve ctDNA extraction recovery, and iii) to use next generation sequencing (NGS) technology to analyze KRAS, BRAF, and NRAS somatic mutations in ctDNA from patients with metastatic colorectal cancer. Venous blood was obtained from patients who suffered from metastatic colorectal carcinoma. For plasma ctDNA extraction, the following carriers were tested: carrier RNA, polyadenylic acid, glycogen, linear acrylamide, yeast tRNA, salmon sperm DNA, and herring sperm DNA. Each extract was characterized by quantitative real-time PCR and next generation sequencing. The addition of polyadenylic acid had a significant positive effect on the amount of ctDNA eluted. The sequencing data revealed five cases of ctDNA mutated in KRAS and one patient with a BRAF mutation. An agreement of 86% was found between tumor tissues and ctDNA. Testing somatic mutations in ctDNA seems to be a promising tool to monitor dynamically changing genotypes of tumor cells circulating in the body. The optimized process of ctDNA extraction should help to obtain more reliable sequencing data in patients with metastatic colorectal cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17010615
003      
CZ-PrNML
005      
20240904092215.0
007      
ta
008      
170321s2016 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.14712/18059694.2016.54 $2 doi
035    __
$a (PubMed)27526306
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Beránek, Martin, $u Department of Biochemical Sciences, Charles University, Faculty of Pharmacy in Hradec Králové, Czech Republic; Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic $d 1968- $7 xx0044204
245    10
$a Carrier molecules and extraction of circulating tumor DNA for next generation sequencing in colorectal cancer / $c M. Beránek, I. Sirák, M. Vošmik, J. Petera, M. Drastíková, V. Palička
520    9_
$a The aims of the study were: i) to compare circulating tumor DNA (ctDNA) yields obtained by different manual extraction procedures, ii) to evaluate the addition of various carrier molecules into the plasma to improve ctDNA extraction recovery, and iii) to use next generation sequencing (NGS) technology to analyze KRAS, BRAF, and NRAS somatic mutations in ctDNA from patients with metastatic colorectal cancer. Venous blood was obtained from patients who suffered from metastatic colorectal carcinoma. For plasma ctDNA extraction, the following carriers were tested: carrier RNA, polyadenylic acid, glycogen, linear acrylamide, yeast tRNA, salmon sperm DNA, and herring sperm DNA. Each extract was characterized by quantitative real-time PCR and next generation sequencing. The addition of polyadenylic acid had a significant positive effect on the amount of ctDNA eluted. The sequencing data revealed five cases of ctDNA mutated in KRAS and one patient with a BRAF mutation. An agreement of 86% was found between tumor tissues and ctDNA. Testing somatic mutations in ctDNA seems to be a promising tool to monitor dynamically changing genotypes of tumor cells circulating in the body. The optimized process of ctDNA extraction should help to obtain more reliable sequencing data in patients with metastatic colorectal cancer.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a transportní proteiny $x krev $7 D002352
650    _2
$a kolorektální nádory $x krev $x diagnóza $x genetika $x patologie $7 D015179
650    _2
$a mutační analýza DNA $7 D004252
650    _2
$a DNA nádorová $x krev $x genetika $x izolace a purifikace $7 D004273
650    _2
$a ženské pohlaví $7 D005260
650    12
$a vysoce účinné nukleotidové sekvenování $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a metastázy nádorů $7 D009362
650    _2
$a prognóza $7 D011379
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sirák, Igor $u Department of Oncology, University Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic $7 xx0135409
700    1_
$a Vošmik, Milan, $u Department of Oncology, University Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic $d 1972- $7 xx0135408
700    1_
$a Petera, Jiří, $u Department of Oncology, University Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic $d 1959- $7 xx0000229
700    1_
$a Drastíková, Monika $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic $7 xx0321911
700    1_
$a Palička, Vladimír, $d 1946- $7 jn99240000830 $u Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Charles University, Faculty of Medicine in Hradec Králové, Czech Republic
773    0_
$w MED00010947 $t Acta Medica $x 1211-4286 $g Roč. 59, č. 2 (2016), s. 54-58
856    41
$u https://actamedica.lfhk.cuni.cz/media/pdf/18059694.2016.54.pdf $y plný text volně přístupný
910    __
$a ABA008 $b A 3077 $c 1072 $y 4 $z 0
990    __
$a 20170321 $b ABA008
991    __
$a 20240904092211 $b ABA008
999    __
$a ok $b bmc $g 1196368 $s 971332
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 59 $c 2 $d 54-58 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
LZP    __
$b NLK118 $a Pubmed-20170321
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace